Fairmount Funds Management LLC

Holdings History for Enliven Therapeutics, Inc. - Common Stock, par value $0.001 per share (ELVN)

Symbol: ELVN on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 3.2M shares
Security Ownership: 6.6%

Shares, Excluding Options vs Price

Value, Excluding Options

Fairmount Funds Management LLC ownership in Enliven Therapeutics, Inc. Common Stock, par value $0.001 per share (ELVN)

2025-02-14 - Fairmount Funds Management LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.2M shares of Enliven Therapeutics, Inc. Common Stock, par value $0.001 per share (ELVN). This represents 6.6% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Fairmount Funds Management LLC	6.6%		$65M	3.2M			$20.29	13G/A	12/31/2024	14 Feb 2025 15:45:06

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	7.16%		$72.1M	3.2M			$22.50	Q4 2024
9/30/2024	6.63%		$81.8M	3.2M			$25.54	Q3 2024
6/30/2024	8.46%		$74.8M	3.2M			$23.37	Q2 2024
3/31/2024	6.14%	+1.99%	$56.3M	3.2M	+1,071,429	+50.3%	$17.59	Q1 2024
12/31/2023	3.12%		$29.5M	2.13M			$13.84	Q4 2023
9/30/2023	3.5%	+0.01%	$29.1M	2.13M	+6,744	+0.32%	$13.66	Q3 2023
6/30/2023	6.11%	+0.57%	$43.4M	2.12M	+199,687	+10.4%	$20.41	Q2 2023
3/31/2023	7.25%	+7.25%	$42.2M	1.92M	+1,924,938	NEW	$21.90	Q1 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.